APA (7th ed.) Citation

Than, M. T., Dequiedt, L., Sor, R., Nair, S., Markosyan, N., Furth, E. E., . . . Stanger, B. Z. (2026). Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma. Science, 391(6790), 1161. https://doi.org/10.1126/science.aec7929

Chicago Style (17th ed.) Citation

Than, Minh T., et al. "Cancer Interception with KRAS Inhibitors in Preclinical Models of Pancreatic Ductal Adenocarcinoma." Science 391, no. 6790 (2026): 1161. https://doi.org/10.1126/science.aec7929.

MLA (9th ed.) Citation

Than, Minh T., et al. "Cancer Interception with KRAS Inhibitors in Preclinical Models of Pancreatic Ductal Adenocarcinoma." Science, vol. 391, no. 6790, 2026, p. 1161, https://doi.org/10.1126/science.aec7929.